Sun Pharma, Hetero recall drugs in US market

New Delhi: Drug makers Sun Pharma and Hetero are recalling products in the US market for manufacturing issues, ac- cording to the US Food and Drug Administration (USFDA).

As per the US health raga- latter’s latest Enforcement Re- port, the US-based arm of Sun Pharmaceutical Industries is recalling a generic drug Indi- catted to raise blood pressure in adult patients with acute hypotension.

Princeton (New Jersey) based Sun Pharmaceutical Inc is recalling 16,450 vials of Norepinephrine Bitartrate Injection for “Failed Impure- ties/Degradation Specific- tins”, it said.

Sun Pharma, Hetero recall ,
Sun Pharma, Hetero recall

The affected lot has been manufactured by Hyderabad- based Gland Pharma and distributed in the US by Sun Pharmaceutical Industries, the USFDA stated. Sun Phar- pharmaceutical Inc initiated the Class III nationwide recall (US) on March 29 this year.

In a separate disclosure, the USFDA said the US-based arm of Hetero Labs is recall- in a drug used to treat certain stomach and esophagus problems. Hetero USA Inc is recalling 2,352 bottles of Pantoprazole Sodium delayed release tablets for “CGMP Deviations: Discoloration”, the USFDA stated. The affected lot was produced by Hetero Labs for New Jersey-based Camber Pharmaceuticals Inc, it added.

Home Facebook Tour Graphic Design Grocery Karnataka Rishikesh Dandeli Fashion





Leave a Reply

Your email address will not be published. Required fields are marked *